Generation of induced cardiac progenitor cells via somatic reprogramming.

Generation of induced cardiac progenitor cells via somatic reprogramming.

Oncotarget. 2017 Feb 10;:

Authors: Xu J, Lian W, Li L, Huang Z

Abstract
It has been demonstrated that cardiac progenitor cells (CPCs) represent a more effective cell-based therapy for treatment of myocardial infarction. Unfortunately, their therapeutic application is limited by low yield of cell harvesting, declining quality and quantity during the ageing process, and the need for highly invasive heart biopsy. Therefore, there is an emerging interest in generating CPC-like stem cells from somatic cells via somatic reprogramming. This novel approach would provide an unlimited source of stem cells with cardiac differentiation potential. Here we would firstly discuss the different types of CPC and their importance in stem cell therapy for treatment of myocardial infarction; secondly, the necessity of generating induced CPC from somatic cells via somatic reprogramming; and finally the current progress of somatic reprogramming in cardiac cells, especially induced CPC generation.

PMID: 28199972 [PubMed - as supplied by publisher]

http://ift.tt/2lVnyp7